Market Closed -
Nasdaq Helsinki
12:00:00 2024-06-10 pm EDT
|
5-day change
|
1st Jan Change
|
4.28
EUR
|
+1.90%
|
|
+3.56%
|
+5.16%
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,042
|
2,108
|
-
|
-
|
Enterprise Value (EV)
1 |
2,042
|
2,108
|
2,108
|
2,108
|
P/E ratio
|
12.7
x
|
12.3
x
|
13.5
x
|
13.5
x
|
Yield
|
8.11%
|
7.91%
|
7.99%
|
7.73%
|
Capitalization / Revenue
|
6,040,558
x
|
-
|
-
|
-
|
EV / Revenue
|
6,040,558
x
|
-
|
-
|
-
|
EV / EBITDA
|
11,154,084
x
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
Price to Book
|
1.28
x
|
1.31
x
|
1.28
x
|
1.4
x
|
Nbr of stocks (in thousands)
|
501,797
|
501,797
|
-
|
-
|
Reference price
2 |
4.070
|
4.200
|
4.200
|
4.200
|
Announcement Date
|
2/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Net sales
|
338.1
|
-
|
-
|
-
|
EBITDA
|
183.1
|
-
|
-
|
-
|
EBIT
1 |
178.3
|
199.9
|
189
|
179.5
|
Operating Margin
|
52.74%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
210.4
|
213.4
|
194.1
|
194.5
|
Net income
1 |
160.7
|
168.2
|
151.7
|
150.2
|
Net margin
|
47.53%
|
-
|
-
|
-
|
EPS
2 |
0.3200
|
0.3409
|
0.3120
|
0.3106
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.3300
|
0.3322
|
0.3357
|
0.3247
|
Announcement Date
|
2/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q1
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
|
-
|
-
|
-
|
-
|
167.6
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
-
|
-
|
51.3
|
-
|
51.53
|
50.89
|
50.62
|
Operating Margin
|
-
|
-
|
-
|
-
|
30.61%
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
83.9
|
46.3
|
130.2
|
46.9
|
-
|
-
|
-
|
Net income
|
23.6
|
63.3
|
68.2
|
29.2
|
97.4
|
37.8
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
58.11%
|
-
|
-
|
-
|
-
|
EPS
|
-
|
0.3000
|
-
|
0.0600
|
0.0200
|
0.0800
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/10/23
|
8/16/23
|
11/8/23
|
2/13/24
|
2/13/24
|
5/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
9.8%
|
10.6%
|
10.5%
|
10.1%
|
ROA (Net income/ Total Assets)
|
1.03%
|
1.05%
|
0.96%
|
0.84%
|
Assets
1 |
15,596
|
16,030
|
15,786
|
17,833
|
Book Value Per Share
2 |
3.190
|
3.200
|
3.280
|
3.000
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/13/24
|
-
|
-
|
-
|
Average target price
4
EUR Spread / Average Target -4.76% Consensus |
1st Jan change
|
Capi.
|
---|
| +4.72% | 2.28B | | +9.43% | 78.94B | | +7.62% | 50.45B | | +5.93% | 49.81B | | +21.55% | 46.31B | | +13.62% | 42.31B | | +23.63% | 39.83B | | -1.75% | 28.46B | | -8.98% | 27.07B | | +27.21% | 26.32B |
Other Life & Health Insurance
|